Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2003 Mar;60(3):557–566. doi: 10.1007/s000180300047

U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping

C Brun 1, D Suter 1, C Pauli 1, P Dunant 2, H Lochmüller 2, J-M Burgunder 3, D Schümperli 4, J Weis 1
PMCID: PMC11138867  PMID: 12737315

Abstract.

Most cases of Duchenne muscular dystrophy are caused by dystrophin gene mutations that disrupt the mRNA reading frame. Artificial exclusion (skipping) of a single exon would often restore the reading frame, giving rise to a shorter, but still functional dystrophin protein. Here, we analyzed the ability of antisense U7 small nuclear (sn)RNA derivatives to alter dystrophin pre-mRNA splicing. As a proof of principle, we first targeted the splice sites flanking exon 23 of dystrophin pre-mRNA in the wild-type muscle cell line C2C12 and showed precise exon 23 skipping. The same strategy was then successfully adapted to dystrophic immortalized mdx muscle cells where exon-23-skipped dystrophin mRNA rescued dystrophin protein synthesis. Moreover, we observed a stimulation of antisense U7 snRNA expression by the murine muscle creatine kinase enhancer. These results demonstrate that alteration of dystrophin pre-mRNA splicing could correct dystrophin gene mutations by expression of specific U7 snRNA constructs.

Keywords: Key words. Duchenne muscular dystrophy; dystrophin; exon skipping; gene therapy; pre-mRNA; U7 snRNA.

Footnotes

Received 2 December 2002; received after revision 15 January 2003; accepted 22 January 2003

RID="*"

ID="*"Corresponding author.


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES